Pegenzileukin

Generic Name: Pegenzileukin

Brand Names: -

Drug Type: Biotech

Chemical Formula: -

CAS Number: 2573074-47-0

Unique Ingredient Identifier: 10WR240QN7

Associated Conditions: -

Associated Therapies: -

Clinical Trials

Isatuximab in Combination With Novel Agents in RRMM - Master Protocol

Phase 1

Recruiting

Conditions: Plasma Cell Myeloma Refractory

Interventions: Drug: Isatuximab
Drug: Dexamethasone
Drug: Pegenzileukin
Drug: Evorpacept
Drug: Pomalidomide
Drug: SAR439459
Drug: Belantamab mafodotin
Drug: Belumosudil

First Posted Date: 2020-11-24

Last Posted Date: 2024-07-05

Lead Sponsor: Sanofi

Target Recruit Count: 197

Registration Number: NCT04643002

Locations: 🇮🇱
Investigational Site Number : 3760002, Jerusalem, Israel
🇫🇷
Investigational Site Number : 2500002, Lille, France
🇫🇷
Investigational Site Number : 2500001, Nantes, France

and more 20 locations

Prev
1
Next

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy